THERE IS NO LONG-TERM SAFETY DATA ON COVID-19 VACCINES
Covid-19 vaccines that have been approved for use under Emergency Use Authorization are still considered experimental. Emergency Use Authorization simply expedites approval for use of an unapproved product in an emergency situation where no other effective therapeutic is available. The trials conducted for these vaccines have provided limited short-term and ZERO long-term safety data. Additionally, routine procedures like animal testing have been completely skipped.
Presentation of adverse reactions to vaccination can span from immediate to well after a vaccine has been administered. Long term safety risks such as carcinogenicity, genetic interference, and latent autoimmune conditions are of concern with the COVID-19 vaccine. The FDA has developed a working list of potential adverse reactions to the COVID-19 vaccine based upon acknowledged adverse reactions to other vaccines. While vaccine adverse reactions are not often talked about, it is acknowledged that particular conditions and biologically plausible reactions occur in relation to vaccines.
Presentation of adverse reactions to vaccination can span from immediate to well after a vaccine has been administered. Long term safety risks such as carcinogenicity, genetic interference, and latent autoimmune conditions are of concern with the COVID-19 vaccine. The FDA has developed a working list of potential adverse reactions to the COVID-19 vaccine based upon acknowledged adverse reactions to other vaccines. While vaccine adverse reactions are not often talked about, it is acknowledged that particular conditions and biologically plausible reactions occur in relation to vaccines.
Short term reactions like anaphylaxis, heart related issues, facial inflammation in recipients with dermal fillers, neurological conditions such as Bell's Palsy, and death have been reported. 21% of participants Moderna's phase 1 trial had a severe adverse reaction to the vaccine. 2 participants of AstraZeneca's vaccine trial suffered Transverse Myelitis (a known adverse reaction to vaccines). Meningococcal vaccine was used in the control group for AstraZeneca's trials, which is not a true placebo.
At a meeting on December 19th, the CDC presented data showing that between Dec. 14 and Dec. 18 272,001 doses of the Pfizer BioNTech vaccine were administered. Of those doses 3,150 “Health Impact Events” were recorded, including 514 events in pregnant women. Those who experienced a "Health Impact Event" were classified as being “unable to perform normal daily activities, unable to work, required care from doctor or health care professional.”
As of January 20, 2023, 1,509,410 adverse events have been reported to the Vaccine Adverse Event Reporting System for Covid-19 vaccine. These include 33,904 deaths, 190,116 hospitalizations, 144,675 urgent care visits, 222,580 office visits, 10,349 anaphylactic reactions, 16,656 Bell's palsy cases, 18,331 heart attacks, 4,893 miscarriages, 42,083 severe allergic reactions, 8,439 cases of thrombocytopenia and 26,289 reports of myocarditis/pericarditis. While it is required by law for healthcare professional to report all vaccine adverse reactions to the system, it has been estimated that only 1% of events ever go reported.
At a meeting on December 19th, the CDC presented data showing that between Dec. 14 and Dec. 18 272,001 doses of the Pfizer BioNTech vaccine were administered. Of those doses 3,150 “Health Impact Events” were recorded, including 514 events in pregnant women. Those who experienced a "Health Impact Event" were classified as being “unable to perform normal daily activities, unable to work, required care from doctor or health care professional.”
As of January 20, 2023, 1,509,410 adverse events have been reported to the Vaccine Adverse Event Reporting System for Covid-19 vaccine. These include 33,904 deaths, 190,116 hospitalizations, 144,675 urgent care visits, 222,580 office visits, 10,349 anaphylactic reactions, 16,656 Bell's palsy cases, 18,331 heart attacks, 4,893 miscarriages, 42,083 severe allergic reactions, 8,439 cases of thrombocytopenia and 26,289 reports of myocarditis/pericarditis. While it is required by law for healthcare professional to report all vaccine adverse reactions to the system, it has been estimated that only 1% of events ever go reported.
SOURCES
Myocarditis and Pericarditis following receipt of mRNA COVID-19 vaccines
CDC data on COVID-19 vaccine induced Myocarditis and Pericarditis
Vaccine Adverse Events Reporting System
Searchable database of reported adverse reactions to vaccines
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
Presentation from CDC meeting regarding anaphylaxis and Health Impact Events
Report and Adverse Event
Information to report and adverse reaction to a vaccine
Moderna Phase 1 Trial
21% of participants suffered serious adverse reaction
AstraZeneca COVID-19 Vaccine Trial Results
Reference to serious adverse reactions including Transverse Myelitis
Moderna's COVID-19 Vaccine Side Effects with Facial Fillers
Reference to adverse reaction of facial swelling in vaccine recipients with fillers
CDC data on COVID-19 vaccine induced Myocarditis and Pericarditis
Vaccine Adverse Events Reporting System
Searchable database of reported adverse reactions to vaccines
Anaphylaxis Following m-RNA COVID-19 Vaccine Receipt
Presentation from CDC meeting regarding anaphylaxis and Health Impact Events
Report and Adverse Event
Information to report and adverse reaction to a vaccine
Moderna Phase 1 Trial
21% of participants suffered serious adverse reaction
AstraZeneca COVID-19 Vaccine Trial Results
Reference to serious adverse reactions including Transverse Myelitis
Moderna's COVID-19 Vaccine Side Effects with Facial Fillers
Reference to adverse reaction of facial swelling in vaccine recipients with fillers